Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
13.79 Down 0.44(3.09%) Apr 23, 4:00PM EDT
|After Hours : 13.87 Up 0.08 (0.58%) Apr 23, 6:26PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   7,000  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   7,000  
Operating Expenses
Research Development8,863  10,351  6,934  6,239  
Selling General and Administrative8,876  5,381  4,520  2,919  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (17,739) (15,732) (11,454) (2,158)
Income from Continuing Operations
Total Other Income/Expenses Net71  81  96  103  
Earnings Before Interest And Taxes(17,668)(15,651)(11,358)(2,055)
Interest Expense -   -   -   -  
Income Before Tax(17,668)(15,651)(11,358)(2,055)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(17,668)(15,651)(11,358)(2,055)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (17,668) (15,651) (11,358) (2,055)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (17,668) (15,651) (11,358) (2,055)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.